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Objectives To determine the diversity of pulsed-field gel electrophoresis (PFGE) types among epidemic
strains of methicillin-resistant Staphylococcus aureus (MRSA) recovered in Belgium, France, Germany and The
Netherlands over the period 1981–94.
Methods MRSA strains collected in a multicenter survey in Belgium (n = 171) and from reference laboratories
in neighboring countries (n = 102) were characterized by PFGE analysis using the SmaI enzyme.
Results In total, 32 PFGE types were found. Epidemic PFGE type 1, first recognized in 1984, accounted for
82% of Belgian strains (87% of hospitals) and 51% of European MRSA strains. Four other internationally
epidemic PFGE types (types 8, 10, 11 and 12) were less widely disseminated and more recently detected (1991–
94), each recovered from two or three countries. International spread of two PFGE types was linked to transfer
of colonized patients to Dutch hospitals from another country where this type was frequently recovered.
Conclusions Genotypic analysis indicated widespread distribution of several outbreak-associated MRSA
strains over large European regions, which was in some instances related to interhospital patient transfer. These
findings underscore the need for standardized international surveillance and control of MRSA transmission
between healthcare institutions across Europe.
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INTRODUCTION
In the past decade, methicillin-resistant Staphylococcus aureus
(MRSA) strains have become major nosocomial pathogens [1]
worldwide. In Europe, the prevalence of MRSA varies widely
between countries and is consistently higher in southern coun-
tries like Italy, Spain and France, which report more than
30% as compared with less than 2% in northern parts such as
Scandinavia, The Netherlands and Switzerland [2]. In Belgium,
a national survey of bloodstream isolates conducted in 1989–
91 in 144 Belgian acute-care hospitals showed a mean MRSA
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prevalence of 14% (range 0–70%) [3]. A more recent survey of
S. aureus bacteremia conducted in 83 hospitals in 1995 showed
that MRSA accounts for 21% of isolates [4]. Multiple studies
have shown clonal spread of epidemic MRSA strains within
hospitals [5,6], between hospitals within a country [7,8] and
also between countries [9,10]. These events have been linked to
interhospital transfer of either colonized patients or healthcare
workers.
Epidemiologic typing of MRSA can be achieved by a num-
ber of molecular methods [5–12]. Pulsed-field gel elec-
trophoresis (PFGE) of genomic macrorestriction fragments has
been recommended as a standard [13]. The advantages of PFGE
include full typability, good reproducibility within centers,
recognizable stability of genomic pattern relatedness over years
and high discriminatory power. The usefulness of PFGE in
monitoring the spread of epidemic MRSA strains at national
or international level is well documented [5,7,10].
The first objective of our study was to determine the
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geographic spread and diversity of PFGE types of epidemic
Belgian MRSA from a national surveillance survey conducted
in 1991–92. The second goal was to compare the relatedness
of PFGE types of epidemic MRSA strains collected by reference





During a Belgian survey conducted by the Groupement pour
le Depistage et la Pre´vention des Infections Hospitalie`res (GDE-
PIH-GOSPIZ) in 1991–92, up to 10 non-duplicate, con-
secutive MRSA isolates were collected from in-patients in 111
participating hospitals. Among these hospitals, 80 sent five or
more MRSA strains representing a total of 681 isolates that
were screened by phage typing.
Three sets of MRSA strains were selected from this survey
for molecular typing. A first set included a random sample of
72 isolates taken from each hospital with one or more locally
epidemic phage type(s), defined as identical phage types reco-
vered from 3 patients in a given hospital (Table 1). The
second set of 57 strains originated from six hospitals during a
local MRSA outbreak (i.e. a significant increase in local MRSA
prevalence in 1989–91). The third set included 42 MRSA
strains collected in five hospitals with an endemic MRSA setting
(stable MRSA prevalence during 1989–91) [3].
European survey
European MRSA strains (n = 102) were selected by national
reference centers in Belgium, France, Germany and The
Netherlands to include: (1) strains associated with epidemics in
one or more hospitals; (2) strains collected during the period
1983–94; and (3) if any, MRSA strains with phage type 77 or
47/54/75/77/84/85, frequent epidemic phage types in
Belgium during this period. This collection included strains
from Belgium (n = 38, 1981–92), France (n = 24, 1985–94),
Germany (n = 22, 1983–93) and The Netherlands (n = 18,
1985–94).
Antimicrobial susceptibility
MRSA isolates were confirmed by the oxacillin agar screen
method and by multiplex PCR detection of mecA and nuc genes
[14]. Minimal inhibitory concentration (MIC) determination
was performed by the agar dilution method following NCCLS
recommendations [15] for 17 antimicrobials (oxacillin, amoxi-
cillin–clavulanic acid, vancomycin, teicoplanin, erythromycin,
clindamycin, ciprofloxacin, gentamicin, amikacin, netilmicin,
minocycline, rifampin, chloramphenicol, co-trimoxazole, fuci-
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din, imipenem and mupirocin) on 587 MRSA isolates from the
Belgian survey. For interpretation of results, NCCLS break-
points were used, except for fusidic acid, for which the Comite´
de l’Antibiogramme-Socie´te´ Franc¸aise de Microbiologie (CA-
SFM) breakpoints of 2–32 mg/mL were used, and for mupi-
rocin, for which 2–512 mg/mL breakpoints were used, as re-
commended by the manufacturer. Strains presenting
intermediate MIC values were considered resistant.
Phage typing
The international basic set of phages was used at routine test
dilution (RTD) and at RTD  100 for strains non-typable at
RTD [6]. Phage types were considered to be identical if  1
phage difference was observed.
Macrorestriction analysis
Genomic DNA extraction and SmaI restriction were performed
as described before [6]. DNA fragments were separated by
PFGE in a CHEF-Mapper system (Bio-Rad Laboratories, Naz-
areth, Belgium), using pulsing parameters of 5–15 s for 10 h
followed by 15–45 s for 15 h. The SmaI genomic digest of S.
aureus NCTC 8325 was used as molecular size marker.
Analysis of PFGE patterns
The similarity of macrorestriction patterns was determined both
by visual comparison and by computer matching. Patterns dif-
fering by more than three fragments were considered to be
distinct clones, and those differing by 1–3 fragments subclonal
variants or subclones [6]. Polaroid negatives were scanned using
the ScanJet II P system (Hewlett Packard, Brussels, Belgium)
into TIFF files which were imported in GelCompar version
4.0 (Applied Maths, Kortrijk, Belgium). Bands in the size range
between 36 and 700 kb were analyzed by Dice similarity coef-
ficient with a position tolerance set to 0.8%. A dendrogram of
similarity was built using the unweighted pair-group method
using arithmetic averages (UPGMA). Clonal group level was set




Of the 681 MRSA isolates, 185 (27%) were non-typable at
RTD by the international set of phages. Among 496 typable
MRSA strains, 237 (48%) belonged to type ‘77’, 138 (28%)
beloned to type ‘47/54/75/77/84/85’, and 121 (24%) were
divided into 35 distinct phage types, none of which included
more than 4% of strains. Locally frequent epidemic phage types
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Table 1 Distribution of Belgian epidemic MRSA strains (n = 72) by PFGE type, antibiotype and phage type
SmaI type Antibiotypea Phage typeb No. of hospitals
1a Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 77 19
1a Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 77/84 2
1a Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi (77) or (47/77) 3
1a Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 47/77/84 1
1a Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 47/75/77/84/85 1
1a Gent, Netil, Cip, Ery, Rif, Aug, Imi (84) 1
1a ND (47/54/75/77) 1
1b Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 42E/47/54/75/77/84/85 12
1b Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 75/77/84/85 1
1b Gent, Netil, Cip, Ery, Clin, Rif, Aug 54/75/77/84/85 1
1b ND 47/53/54/75/77/83A/85 1
1c Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 77 2
1c Amik, Gent, Cip, Rif, Aug, Imi 77/84 or 77 or (47/77) 4
1d Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 54/77 1
1e Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 77 1
1f Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 77 1
1g Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi (77) 1
1h Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 77 1
1i ND 77 1
1j ND 29/47/54/75/77/84/85 1
1k Gent, Netil, Cip, Ery, Rif, Aug 77/84/85 1
1l Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi (75/77/85) 1
1m ND 47/54/75/85 1
2a Cip, Ery, Aug 85 2
2b Cip, Ery, Aug (42E/47/54/74/77/84/85) 1
2c Cip, Ery, Aug (42E/47/54/74/77/84/85) 1
3a Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 77 1
3b Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 77 1
3b Gent, Cip, Ery, Clin, Rif, Aug, Imi 77 1
4 Gent, Netil, Cip, Ery, Aug, Imi 84 1
5 Amik, Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi 77 1
6 Gent, Netil, Cip, Ery, Clin, Rif, Aug, Imi, Chlo, Fos 75/77/84/85 1
7 Cip, Ery, Aug 42E/47/54/75/77/84 1
8 Amik, Cip, Rif, Aug, Sxt 6/47/54/75 1
9 Gent, Netil, Cip, Ery, Rif, Aug 42E/47 1
a Resistance profile, resistant to: Amik, amikacin; Gent, gentamicin; Netil, netilmicin; Cip, ciprofloxacin; Ery, erythromycin; Clin, clindamycin;
Rif, rifampin; Aug, amoxycillin–clavulanic acid; Imi, imipenem; Chlo, chloramphenicol; Fos, fosfomycin; Sxt, co-trimoxazole; ND, not done.
b If untypable at RTD, phage type at RTD X 100 was tested and is shown in brackets.
were predominantly type ‘77’, recovered in 34 (55%) hospitals,
and type ‘47/54/75/77/84/85’, found in 14 (23%) (Table 1).
Antimicrobial susceptibility
The majority of MRSA strains analyzed were resistant to
amoxicillin–clavulanic acid (96%), erythromycin (87%), clin-
damycin (82%), ciprofloxacin (94%) and gentamicin (90%).
Among these strains, 57% were resistant to netilmicin, and only
15% and 9% were resistant to rifampin and co-trimoxazole,
respectively. No strain was resistant to fusidic acid, mupirocin,
vancomycin or teicoplanin. The resistance phenotype of locally
epidemic MRSA strains is shown in Table 1. The most
frequent, antibiotype 1, was resistant to multiple antibiotics
(Table 1).
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PFGE typing
SmaI macrorestriction analysis of 72 MRSA strains presenting
a locally epidemic phage type showed 24 patterns, which clus-
tered into nine major types (Table 1). Computer analysis
showed three predominant groups of strains which clustered
into closely related ( 80%) patterns (PFGE types 1, 2 and 3).
The similarity between major PFGE types ranged from 36% to
72%. Three regionally epidemic types (types 1, 2 and 3) were
found in  2 hospitals. These epidemic types 1, 2 and 3 each
represented 82%, 6% and 4% of all strains, respectively. Type 1
strains were subdivided into 13 subtypes by minor variations
(1–3 bands) in the PFGE fragment patterns. The predominant
subtypes 1a and 1b represented, respectively, 47% and 25% of
type 1 strains.
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The geographic distribution of type 1 strains showed dis-
semination to 54 (87%) Belgian hospitals located in eight of the
nine provinces. They were present in 12 of 13 hospitals in
Brussels. Type 2 strains were found in four (6%) hospitals
located in Brussels and West-Flanders. Type 3 strains were
found in three distant hospitals. Six types were found in a single
hospital from the northern part of Belgium.
Concordance between PFGE analysis and phenotypic methods
The agreement between phage type and major PFGE types
was low (57%). A better concordance was found for phage
type 77-PFGE 1a (86% agreement) and phage type
47/54/75/77/84/85-PFGE 1b (80% agreement) (Table 1).
These subtypes were distinguished by a shift of mobility of
a single SmaI chromosomal DNA fragment from 324 kb to
262 kb.
Resistance patterns showed a concordance of 87% with
PFGE types, with an excellent correlation between major
PFGE type 1 and antibiotype 1 (94%) and between type 2 and
antibiotype 2 (100%). Type 1 was resistant to 11 antibiotics
(oxacillin, amoxycillin–clavulanic acid, rifampin, gentamicin,
amikacin, netilmicin, ciprofloxacin, erythromycin, clin-
damycin, imipenem and co-trimoxazole). In contrast, type 2
strains were consistently susceptible to rifampin, gentamicin,
amikacin, clindamycin, netilmicin and imipenem.
Correlation between PFGE type distribution and local MRSA preva-
lence
Type 1 strains were more frequently represented in six hospitals
in an epidemic setting as compared with five hospitals in an
endemic setting, 80% versus 60% of strains (P = 0.005, Chi-
square test). In these endemic hospitals, 14 sporadic PFGE types
were found (each in a single patient), while in the epidemic
hospitals, eight sporadic types were found, indicating a greater
diversity of types in endemic hospitals.
European survey
PFGE analysis
MRSA isolates showed 78 SmaI patterns that clustered above
80% similarity into 32 major PFGE types by computer analysis
(Figure 1). By visual inspection, the same classification was
obtained based on maximum three-fragment differences, except
for 10 strains, which showed 2–4 fragment differences and 78–
80% Dice coefficient of similarity with type 1 (type 1-related
strains in Figure 1).
Five groups of closely (80% similarity) related PFGE types
appeared to be internationally disseminated (Figure 1). The
most widespread group was type 1, regrouping 42 strains from
several regions of the four countries (Figure 1). Type 1 strains
were isolated during the entire study period (1984–94). Each
of the four other internationally epidemic types was present in
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two or three countries: type 8 was found in Belgium and
France, type 11 in France and The Netherlands, type 12 in
Germany and The Netherlands, and type 10 in Belgium, France
and Germany (Figures 1 and 2). Outbreaks due to epidemic
PFGE types 1 and 11 occurred in Dutch hospitals after transfer
from a French hospital of a patient carrying a strain of these
types. In addition, eight regionally epidemic types were found
in several hospitals within one country, as follows: Germany,
types 14, 16 and 27; The Netherlands, types 20 and 28; and
Belgium, types 2 and 18.
DISCUSSION
This survey of epidemiologically documented MRSA strains
from four western-European countries provides evidence of
international spread of five epidemic MRSA strains. Molecular
epidemiologic studies have demonstrated the spread of domi-
nant MRSA clones in a number of European countries, includ-
ing the UK [2,9], France [8,12], Spain and Portugal [5],
Germany [10], Hungary [7] and Italy [9]. In our study, the most
frequently represented clonal group of MRSA, described here
as type 1 strains, was highly multiresistant. It was present in
France and Belgium in the 1980s and was found to be associated
with epidemics in The Netherlands and Germany in the 1990s.
Local epidemics in The Netherlands were related to patient
transfers from hospitals in France and Turkey. This clonal group
1 presented a considerable diversity of subclonal PFGE types in
both European and Belgian isolates, which may be related to
its relatively ‘long’ evolutionary history (on a microevolution
scale) associated with its successful adaptation to a large human
population reservoir in many different hospital ecosystems.
Type 1 strains were closely similar by all markers used in our
laboratory to type strains of the Iberian clone described by de
Lencastre and colleagues [5]. Four other epidemic MRSA types
appeared to be internationally disseminated in the 1990s but
showed less extensive geographic ranges.
The comprehensive survey of MRSA strains from Belgian
hospitals was conducted in the early 1990s, at a time when
multiple local outbreaks were reported and the frequency of
MRSA was rapidly increasing in many centers [3]. It revealed
nine major PFGE types, three of which appeared to be
regionally epidemic. The frequency of epidemic types by hos-
pital was statistically associated with a recently increasing preva-
lence of MRSA. The predominant epidemic type 1 strains
were multiresistant to antimicrobials and showed two major
phage types. They were recovered from most Belgian hospitals,
located in all parts of the country and in both epidemic and
endemic settings. Two other regionally epidemic types were
present in fewer Belgian hospitals. One of them, type 2,
included strains which were susceptible to gentamicin, amika-
cin, and clindamycin and exhibited a PFGE profile very distant
from that of type 1. Additional studies indicated that type
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Figure 1 SmaI type distribution and dendrogram of relatedness of epidemic MRSA strains from four European countries. International
epidemic MRSA clones which appear to be disseminated in 2 countries are indicated within a frame. The letter code for each country is: B
(Belgium), F (France), G (Germany) and N (The Netherlands).
Figure 2 Map of Belgium, France, Germany and The Netherlands,
indicating the area of dissemination of international epidemic MRSA
clones.
2 strains lack the aacA–aphD gene encoding the bifunctional
aminoglycoside-modifying enzyme, which was carried by type
1 strains [16]. In contrast, type 2 strains showed an even higher
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level of resistance to ciprofloxacin (MIC  128 mg/L) as com-
pared with type 1 strains (MIC 32–64 mg/L) [17]. This extreme
level of resistance to fluoroquinolones may have conferred a
selective advantage to these strains for transmission in hospital
settings characterized by massive use of fluoroquinolones during
that period.
Phage typing has long been used as a reference S. aureus
typing method, but it is hampered by a substantial proportion
of non-typable MRSA isolates and by variability of patterns,
thereby leading to its replacement by PFGE typing in some
reference laboratories [13]. For clonal delineation of S. aureus,
PFGE analysis has emerged as one of the most discriminating
methods. This method can detect some genomic modifications
that arise from mutation in the recognition sites of the enzyme
used and from recombination, deletion or insertion that affect
the fragment size [6,18]. During hospital outbreaks lasting for
over a few years, subclonal PFGE variants of MRSA strains
show size variation of one to three chromosomal fragments
[6,19]. Greater variation in pulsotypes was observed during
subclonal evolution of endemic MRSA over three decades in
one hospital [20]. In the present survey of MRSA strains associ-
ated with outbreaks in a large number of hospitals from Euro-
pean countries over more than a decade, PFGE analysis
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indicated substantial genotypic heterogeneity both at national
and international levels. However, using a conservative defi-
nition of close relatedness between PFGE profiles (80% simi-
larity), a majority of these MRSA strains clustered into a limited
number of closely related pulsotypes, suggesting that they
belonged to the same clonal group and shared the same origin.
The use of additional genotypic markers would be required to
etablish the exact clonal relationships between these MRSA
strains.
These data further document the widespread dissemination
of several epidemic MRSA types across national borders of
western continental Europe, presumably as a result of intra- and
interhospital spread [7–11]. This hypothesis is corroborated by
two lines of evidence. First, we found a significant statistical
association between frequency of type 1 strains and local out-
breaks in Belgian hospitals. Second, two MRSA outbreaks in
The Netherlands were traced to an index patient carrying
MRSA when repatriated from a hospital in a country where
this PFGE type was endemic or epidemic.
These observations have a number of important impli-
cations. Firstly, they underscore the need to coordinate the
strategies to control MRSA nosocomial transmission and pru-
dent management when transferring colonized patients
between institutions at regional and international levels [4].
Second, they stress the importance of improving national and
international surveillance of MRSA infections. This could
involve optimized genotyping methods and a uniform type
nomenclature to track the evolution and diffusion of epidemic
MRSA clones.
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